NCT01667926View on ClinicalTrials.gov

Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

ketamine infusions twice a week for three weeks, total of 6 infusions as augmentation of ongoing antidepressant regimen.

DRUG

Placebo

Trial Locations (1)

02114

Depression Clinical and Reseach Program - MGH, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01667926 - Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder | Biotech Hunter | Biotech Hunter